SCHEDULE 13G/A: UBS Group AG Divests Entire Reportable Stake in Infinera Corp

UBS Group AG has filed an amended Schedule 13G, indicating it no longer beneficially owns any common stock of Infinera Corp as of March 31, 2025.

Summary

• UBS Group AG filed an Amendment No. 1 to Schedule 13G concerning its beneficial ownership of Infinera Corp common stock.
• As of March 31, 2025, UBS Group AG, along with its wholly-owned subsidiary UBS Securities LLC, reported 0 shares beneficially owned.
• This represents 0.0% of Infinera Corp's common stock, indicating a complete divestment of their previously reportable stake.
• The filing certifies that the securities were acquired and held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of a change in beneficial ownership, specifically a reduction to zero, by an institutional investor. It does not contain performance metrics or forward-looking statements that would indicate a positive or negative sentiment for the issuer.

Management Comments

• "The securities referred to were acquired and are held in the ordinary course of business."
• "The securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."

Industry Context

This filing is a standard regulatory disclosure of a change in beneficial ownership by an institutional investor and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: UBS Group AG, a significant institutional investor, has divested its entire reportable stake in Infinera Corp, which could be interpreted by the market as a reallocation of capital or a change in investment strategy regarding the company.

Key Dates

Keywords

Infinera Corp, UBS Group AG, Schedule 13G, beneficial ownership, common stock, SEC filing, institutional investor, divestment